Product Information
CHOLESTYRAMINE LIGHT POWDER is a generic product labeled by TAGI Pharma Inc., priced at $0.1265 per GM under NDC 51224000910. Its NADAC has been published 31 times since Apr 17, 2024.
FDA first approved this application on Nov 12, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 g/4.8g
Manufacturer
TAGI Pharma Inc.NDC
51224000910
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
10/23/2024
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA209599FDA Approved
11/12/2020
TE Code
AB
On Market Since
11/12/2020
Pharmacological Classes
Price Statistics
The NADAC for CHOLESTYRAMINE LIGHT POWDER has been published 31 times since Apr 17, 2024, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1265 per GM |
|---|---|
| All-time high | $0.1432 (Sep 11, 2024) |
| All-time low | $0.1206 (Sep 18, 2024) |
| Median price | $0.1432 |
| Average price | $0.1374 |
| Largest weekly change | -15.8% (Sep 18, 2024) |
| Weeks tracked | 31 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-11.7%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CHOLESTYRAMINE LIGHT POWDER?
The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE LIGHT POWDER, manufactured by TAGI Pharma Inc., is $0.1265 per GM (NDC 51224000910), effective Nov 13, 2024.
How has the price of CHOLESTYRAMINE LIGHT POWDER changed over time?
Over the history we have for it, the NADAC for CHOLESTYRAMINE LIGHT POWDER has declined 11.7%. It has been tracked across 31 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE LIGHT POWDER?
Since Apr 17, 2024, the NADAC for CHOLESTYRAMINE LIGHT POWDER has ranged from a low of $0.1206 (Sep 18, 2024) to a high of $0.1432 (Sep 11, 2024), with a median of $0.1432 per GM.
Are there cheaper alternatives to CHOLESTYRAMINE LIGHT POWDER?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHOLESTYRAMINE POWDER, is $0.0946 per GM — about 25% below CHOLESTYRAMINE LIGHT POWDER.
Who manufactures CHOLESTYRAMINE LIGHT POWDER?
CHOLESTYRAMINE LIGHT POWDER (NDC 51224000910) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.